FindTrial
Sign In

Model development for the prediction of toxicity and prognosis in Korean elderly cancer patients receiving chemotherapy: a multicenter prospective study

Model development for the prediction of toxicity and prognosis in Korean elderly cancer patients receiving chemotherapy: a multicenter prospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001071
Enrollment
200
Registered
2014-04-16
Start date
2014-01-06
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Age: 70 years or more ? Ineligibility for local therapy (surgery or radiotherapy): including inoperable patients due to their medical condition ? Histologically confirmed solid tumor ? Signed in written inforemd consent form

Exclusion criteria

Exclusion criteria: ? Not a candidate for 1st line systemic chemotherapy ? Monotherapy with biologic agent/targeted agent, combination therapy with investigational agent, monotherapy with oral agent ? Hematologic malignancies (lymphoma, leukemia, multiple myeloma etc) ? Recurrent disease within 6 months from last day of adjuvant chemotherapy

Design outcomes

Primary

MeasureTime frame
Grade 3-5 toxicity by NCI-CTC AE version 4.0—

Secondary

MeasureTime frame
survival;drug compliance and frequency of dose modification;bone density and fracture rate—

Countries

Korea, Republic of

Contacts

Public ContactSe Hyun Kim

Seoul National University Bundang Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 26, 2026